Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-05

Clinical Trial Update: The Effects of Nicotinamide Riboside Supplementation on Brain NAD+/NADH Ratio and Bioenergetics [Phase 4]

View source ↗

Summary

Phase 4 trial update studying nicotinamide riboside supplementation effects on brain NAD+/NADH ratio and bioenergetics in healthy participants; trial terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: Mclean Hospital | Conditions: Healthy | Phase 4 | Status: TERMINATED | Results posted: 2024-03-05